Abstract
The problem of acute otitis media in children is discussed in this article. The author describes etiology, pathogenesis and methods of diagnostic of this disease. The article contains information about clinical efficacy and good tolerance of the drug “Otofa” in treatment of acute otitis media in children. The usage of this topic antibacterial agent in complex treatment of acute otitis media is safe in point of systemic side effects and undesirable medicinal interactions, which allows to achieve perfect result and improve life quality of children with inflammatory diseases of middle ear.
Highlights
Острый средний отит у детей в настоящее время представляет серьезную проблему для педиатров многих стран мира
До 95% детей переносят хотя бы один эпизод острого среднего отита за первые 7 лет жизни [4]
The article contains information about clinical efficacy and good tolerance of the drug “Otofa” in treatment of acute otitis media in children. The usage of this topic antibacterial agent in complex treatment of acute otitis media is safe in point of systemic side effects and undesirable medicinal interactions, which allows to achieve perfect result and improve life quality of children with inflammatory diseases of middle ear
Summary
Острый средний отит у детей в настоящее время представляет серьезную проблему для педиатров многих стран мира. До 95% детей переносят хотя бы один эпизод острого среднего отита за первые 7 лет жизни [4]. По данным Организации медицинского обслуживания (HMO, США), у 48% детей отмечаются однократные эпизоды острого перфоративного или неперфоративного среднего отита в первые 6 мес жизни или более В Питтсбургском исследовании среди детей в возрасте от 2 до 5 лет 50% имели один и более эпизодов острого среднего отита [2].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
